Report Detail
Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026
- RnM3475558 |
- 31 December, 2020 |
- Global |
- 91 Pages |
- QYResearch |
- Other
Companion Diagnostic Tests in Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Protein Detection
DNA Detection
Market segment by Application, split into
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes
Others
Based on regional and country-level analysis, the Companion Diagnostic Tests in Oncology market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
In the competitive analysis section of the report, leading as well as prominent players of the global Companion Diagnostic Tests in Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Market Analysis by Type
- 1.3.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2026
- 1.3.2 Protein Detection
- 1.3.3 DNA Detection
- 1.4 Market by Application
- 1.4.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2026
- 1.4.2 Pharmaceutical & Biotechnology Companies
- 1.4.3 Medical Device Companies
- 1.4.4 Research Institutes
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2015-2026)
- 2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
- 2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2015-2020)
- 2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2021-2026)
- 2.3 Companion Diagnostic Tests in Oncology Industry Dynamic
- 2.3.1 Companion Diagnostic Tests in Oncology Market Trends
- 2.3.2 Companion Diagnostic Tests in Oncology Market Drivers
- 2.3.3 Companion Diagnostic Tests in Oncology Market Challenges
- 2.3.4 Companion Diagnostic Tests in Oncology Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Companion Diagnostic Tests in Oncology Players by Market Size
- 3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2015-2020)
- 3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2015-2020)
- 3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
- 3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
- 3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2019
- 3.5 Key Players Companion Diagnostic Tests in Oncology Area Served
- 3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
- 3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests in Oncology Breakdown Data by Type
- 4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2015-2020)
- 4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2021-2026)
5 Companion Diagnostic Tests in Oncology Breakdown Data by Application
- 5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2015-2020)
- 5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
- 6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
- 6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
- 6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2015-2026)
- 7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
- 7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
- 7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2015-2026)
- 8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
- 8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
- 8.4 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
9 Latin America
- 9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2015-2026)
- 9.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
- 9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
- 9.4 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2015-2026)
- 10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2015-2020)
- 10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2015-2020)
- 10.4 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
11Key Players Profiles
- 11.1 Abbott
- 11.1.1 Abbott Company Details
- 11.1.2 Abbott Business Overview
- 11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
- 11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020))
- 11.1.5 Abbott Recent Development
- 11.2 Roche
- 11.2.1 Roche Company Details
- 11.2.2 Roche Business Overview
- 11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
- 11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.2.5 Roche Recent Development
- 11.3 Genomic Health
- 11.3.1 Genomic Health Company Details
- 11.3.2 Genomic Health Business Overview
- 11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
- 11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.3.5 Genomic Health Recent Development
- 11.4 QIAGEN
- 11.4.1 QIAGEN Company Details
- 11.4.2 QIAGEN Business Overview
- 11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
- 11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.4.5 QIAGEN Recent Development
- 11.5 Agilent
- 11.5.1 Agilent Company Details
- 11.5.2 Agilent Business Overview
- 11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
- 11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.5.5 Agilent Recent Development
- 11.6 Agendia
- 11.6.1 Agendia Company Details
- 11.6.2 Agendia Business Overview
- 11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
- 11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.6.5 Agendia Recent Development
- 11.7 BioMerieux
- 11.7.1 BioMerieux Company Details
- 11.7.2 BioMerieux Business Overview
- 11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
- 11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.7.5 BioMerieux Recent Development
- 11.8 Illumina
- 11.8.1 Illumina Company Details
- 11.8.2 Illumina Business Overview
- 11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
- 11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.8.5 Illumina Recent Development
- 11.9 Siemens Healthcare
- 11.9.1 Siemens Healthcare Company Details
- 11.9.2 Siemens Healthcare Business Overview
- 11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
- 11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.9.5 Siemens Healthcare Recent Development
- 11.10 Thermo Fisher
- 11.10.1 Thermo Fisher Company Details
- 11.10.2 Thermo Fisher Business Overview
- 11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
- 11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2015-2020)
- 11.10.5 Thermo Fisher Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Companion Diagnostic Tests in Oncology. Industry analysis & Market Report on Companion Diagnostic Tests in Oncology is a syndicated market report, published as Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Companion Diagnostic Tests in Oncology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
